11Nov
COVID-19 Report for Life Sciences and Health Care Companies (UPDATED)
In Tuesday's Report: the expanding role of real-world evidence in FDA medical device submissions; President-elect Joe Biden lays out COVID-19 plan; Pfizer announces vaccine efficacy; and an analysis of material adverse change (MAC) clauses in Japan....
By:
Hogan Lovells
Related
In this episode of Trekking Through Compliance, we consider the episode A Private Little War which a...
Read More >
The global COVID-19 pandemic has changed how merger enforcement regimes around the world are current...
Read More >
On September 24, 2019 the U.S. Department of Labor (DOL) issued a final rule changing the minimum sa...
Read More >
June 20, 2019 – Walmart (NYSE: WMT) and its subsidiary, WMT Brasilia, agreed to a combined criminal...
Read More >
On the final EMBARGOED! episode of 2020, Brian and Tim present their Top 10 sanctions and export con...
Read More >
As 2019 comes to an end, we are happy to present our traditional End of Year Plan Sponsor “To Do” ...
Read More >